1
|
Brown WV, Remaley AT and Ridker PM: JCL
Roundtable: is inflammation a future target in preventing
arteriosclerotic cardiovascular disease. J Clin Lipidol. 9:119–128.
2015.PubMed/NCBI View Article : Google Scholar
|
2
|
Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen
W, Li X, Wang L, Wang L, Liu Y, et al: Mortality, morbidity, and
risk factors in China and its provinces, 1990-2017: A systematic
analysis for the Global Burden of Disease Study 2017. Lancet.
394:1145–1158. 2019.PubMed/NCBI View Article : Google Scholar
|
3
|
Roth EM: Alirocumab for low-density
lipoprotein cholesterol lowering. Future Cardiol. 15:17–29.
2019.PubMed/NCBI View Article : Google Scholar
|
4
|
Khosravi M, Poursaleh A, Ghasempour G,
Farhad S and Najafi M: The effects of oxidative stress on the
development of atherosclerosis. Biol Chem. 400:711–732.
2019.PubMed/NCBI View Article : Google Scholar
|
5
|
Lankin VZ, Sharapov MG, Goncharov RG,
Tikhaze AK and Novoselov VI: Natural dicarbonyls inhibit peroxidase
activity of peroxiredoxins. Dokl Biochem Biophys. 485:132–134.
2019.PubMed/NCBI View Article : Google Scholar
|
6
|
de Lucia C, Komici K, Borghetti G,
Femminella GD, Bencivenga L, Cannavo A, Corbi G, Ferrara N, Houser
SR, Koch WJ and Rengo G: microRNA in cardiovascular aging and
age-related cardiovascular diseases. Front Med (Lausanne).
4(74)2017.PubMed/NCBI View Article : Google Scholar
|
7
|
Lin D, Xiu-Qing H, Tao S, Lin-Fang LI,
Jian LI and Amp BH: miR-301a regulates the expression of
inflammatory factors in macrophages. Chin J Arterioscler.
25:447–451. 2017.
|
8
|
Dong Y, Yan X, Yang X, Yu C, Deng Y, Song
X and Zhang L: Notoginsenoside R1 suppresses miR-301a via NF-κB
pathway in lipopolysaccharide-treated ATDC5 cells. Exp Mol Pathol.
112(104355)2020.PubMed/NCBI View Article : Google Scholar
|
9
|
Hazra B, Chakraborty S, Bhaskar M,
Mukherjee S, Mahadevan A and Basu A: miR-301a regulates
inflammatory response to japanese encephalitis virus infection via
suppression of NKRF activity. J Immunol. 203:2222–2238.
2019.PubMed/NCBI View Article : Google Scholar
|
10
|
Chen H, Qi J, Bi Q and Zhang S:
Suppression of miR-301a alleviates LPS-induced inflammatory injury
in ATDC5 chondrogenic cells by targeting Sirt1. Int J Clin Exp
Pathol. 10:8991–9000. 2017.PubMed/NCBI
|
11
|
Guan F, Kang Z, Zhang JT, Xue NN, Yin H,
Wang L, Mao BB, Peng WC, Zhang BL, Liang X, et al: KLF7 promotes
polyamine biosynthesis and glioma development through
transcriptionally activating ASL. Biochem Biophys Res Commun.
514:51–57. 2019.PubMed/NCBI View Article : Google Scholar
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
13
|
Wysocka A, Cybulski M, Berbeć H,
Wysokiński A, Stążka J, Daniluk J and Zapolski T: Dynamic changes
of paraoxonase 1 activity towards paroxon and phenyl acetate during
coronary artery surgery. BMC Cardiovasc Disord.
17(92)2017.PubMed/NCBI View Article : Google Scholar
|
14
|
Marenberg ME, Risch N, Berkman LF,
Floderus B and de Faire U: Genetic susceptibility to death from
coronary heart disease in a study of twins. N Engl J Med.
330:1041–1046. 1995.PubMed/NCBI View Article : Google Scholar
|
15
|
Schober A and Weber C: Mechanisms of
MicroRNAs in Atherosclerosis. Annu Rev Pathol. 11:583–616.
2016.PubMed/NCBI View Article : Google Scholar
|
16
|
Pordzik J, Pisarz K, De Rosa S, Jones AD,
Eyileten C, Indolfi C, Malek L and Postula M: The potential role of
platelet-related micrornas in the development of cardiovascular
events in high-risk populations, including diabetic patients: a
review. Front Endocrinol (Lausanne). 9(74)2018.PubMed/NCBI View Article : Google Scholar
|
17
|
Canfrán-Duque A, Rotllan N, Zhang X,
Fernández-Fuertes M, Ramírez-Hidalgo C, Araldi E, Daimiel L, Busto
R, Fernández-Hernando C and Suárez Y: Macrophage deficiency of
miR-21 promotes apoptosis, plaque necrosis, and vascular
inflammation during atherogenesis. EMBO Mol Med. 9:1244–1262.
2017.PubMed/NCBI View Article : Google Scholar
|
18
|
Feng J, Li A, Deng J, Yang Y, Dang L, Ye
Y, Li Y and Zhang W: miR-21 attenuates lipopolysaccharide-induced
lipid accumulation and inflammatory response: Potential role in
cerebrovascular disease. Lipids Health Dis. 13(27)2014.PubMed/NCBI View Article : Google Scholar
|
19
|
Liu L, Yin H, Hao X, Song H, Chai J, Duan
H, Chang Y, Yang L, Wu Y, Han S, et al: Down-Regulation of
miR-301a-3p Reduces Burn-Induced Vascular Endothelial Apoptosis by
potentiating hMSC-Secreted IGF-1 and PI3K/Akt/FOXO3a Pathway.
iScience. 23(101383)2020.PubMed/NCBI View Article : Google Scholar
|
20
|
Li H, Xue M, Xu J and Qin X: MiR-301a is
involved in adipocyte dysfunction during obesity-related
inflammation via suppression of PPARγ. Pharmazie. 71:84–88.
2016.PubMed/NCBI
|
21
|
He C, Shi Y, Wu R, Sun M, Fang L, Wu W,
Liu C, Tang M, Li Z, Wang P, et al: miR-301a promotes intestinal
mucosal inflammation through induction of IL-17A and TNF-α in IBD.
Gut. 65:1938–1950. 2016.PubMed/NCBI View Article : Google Scholar
|
22
|
Domínguez-Andrés J and Netea MG: Long-term
reprogramming of the innate immune system. J Leukoc Biol.
105:329–338. 2019.PubMed/NCBI View Article : Google Scholar
|
23
|
Li WY, Zhang WT, Cheng YX, Liu YC, Zhai
FG, Sun P, Li HT, Deng LX, Zhu XF and Wang Y: Inhibition of
KLF7-Targeting MicroRNA 146b Promotes Sciatic Nerve Regeneration.
Neurosci Bull. 34:419–437. 2018.PubMed/NCBI View Article : Google Scholar
|
24
|
Blackmore MG, Wang Z, Lerch JK, Motti D,
Zhang YP, Shields CB, Lee JK, Goldberg JL, Lemmon VP and Bixby JL:
Krüppel-like Factor 7 engineered for transcriptional activation
promotes axon regeneration in the adult corticospinal tract. Proc
Natl Acad Sci USA. 109:7517–7522. 2012.PubMed/NCBI View Article : Google Scholar
|